Imidin N Nasenspray (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa, it stimulates alpha‑receptors on blood‑vessel smooth muscle, causing vasoconstriction. This reduces blood flow and edema in the nasal lining, decreasing blockage and allowing easier breathing.

The appropriate dose of Imidin N Nasenspray is determined by a healthcare professional. For over‑the‑counter use, the label typically advises a specific number of sprays per nostril, not to exceed the recommended daily maximum, and to limit treatment to a few days. Always follow the prescriber's guidance.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the spray. The prescriber will weigh potential benefits against any possible risks to mother and child.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imidin N Nasenspray contains Xylometazoline, which has a rapid onset of action similar to oxymetazoline but may have a slightly longer duration of effect. Both belong to the alpha‑adrenergic agonist class and share comparable efficacy. Choice often depends on local availability, patient tolerance and prescriber preference.

Store the spray at room temperature, ideally below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and extreme heat. Ensure the cap is tightly closed after each use to maintain product integrity and prevent accidental discharge.

The spray is applied directly into each nostril while the head is upright. Typically, one or two sprays per nostril are used, as directed by the label or a healthcare professional. After spraying, avoid blowing the nose for a few minutes to allow the medication to act.

Serious adverse events, though rare, include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, significant elevation of blood pressure, tachycardia, severe allergic reactions such as anaphylaxis, and nasal tissue damage. If any of these occur, discontinue use and seek medical attention promptly.

Individuals with known hypersensitivity to Xylometazoline or any component of the formulation should avoid the product. It is also contraindicated in patients with severe hypertension, certain cardiovascular disorders, or those who have used other vasoconstrictive nasal sprays within the past 24 hours. Children under six years should not use it without medical advice.